Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Proteomics ; 7(22): 4090-101, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17994630

ABSTRACT

Ovarian cancer is one of the leading causes of mortality by gynecological cancer. Despite good response to surgery and initial chemotherapy, essentially based on cisplatin (cis-diamino-dichloro-platinum(II) (CDDP)) compounds, frequent recurrences with chemoresistance acquisition are responsible for poor prognosis. Several mechanisms have been described as implicated in CDDP resistance, however they are not sufficient to exhaustively account for this resistance emergence. We applied a proteomic approach based on 2-DE coupled with MS (MALDI-TOF/TOF) to identify proteins associated with chemoresistance induced by CDDP. A kinetic analysis of IGROV1 cell behavior following treatment with CDDP and subsequent statistical analysis revealed time and/or concentration-dependent modifications in protein expression. We evidenced events such as decreased amino-acid and nucleotide synthesis potentially associated with cell cycle blockade, and variations that may be related to resistance acquisition, such as possible enhanced glycolysis and increased proliferating potential. Moreover, overexpressions of aldehyde dehydrogenase 1 and both cytokeratins 8 and 18 were consistent with our previous findings, demonstrating that expression of these proteins was increased in cisplatin-resistant IGROV1-R10 as compared to IGROV1 parental cells. Identification of such proteins could allow improved understanding of the mechanisms leading to cell death or survival and, thus, to the acquisition of chemoresistance.


Subject(s)
Adenocarcinoma/drug therapy , Cisplatin/pharmacology , Neoplasm Proteins , Ovarian Neoplasms/drug therapy , Proteomics , Cell Line, Tumor , Cell Survival/drug effects , DNA, Neoplasm/drug effects , Dose-Response Relationship, Drug , Electrophoresis, Gel, Two-Dimensional/methods , Female , Humans , Kinetics , Neoplasm Proteins/analysis , Neoplasm Proteins/drug effects , Reproducibility of Results , Sensitivity and Specificity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Tumor Cells, Cultured
2.
Anticancer Res ; 26(5A): 3561-6, 2006.
Article in English | MEDLINE | ID: mdl-17094483

ABSTRACT

BACKGROUND: 2-Deoxy-D-glucose (2-DG) is an analog of glucose that is preferentially captured by tumors and is accumulated in transformed cells, because the phosphorylated molecule (2-DG-6P) cannot be metabolized or diffused outside the cells. Targeted with a fluorine atom, 18F-DG is currently used to visualize malignant tumors (PET scan). Although cancer cells have been reported to be strongly dependent on glycolysis (Warburg effect), very few reports have studied the inhibitory effects of 2-DG on cancer. MATERIALS AND METHODS: Our objective was to study, in a large panel of human malignant cells of various origins (ovarian, squamous, cerebral, hepatic, colonic and mesothelial), if the inhibitory activity of 2DG against tumor growth could be considered a general phenomenon and to determine its effect on the cell cycle. RESULTS: Four types of response in the different cell lines were observed when cells were cultured in the presence of 2-DG (5 mM) continuous exposure: proliferation slow down; proliferation arrest without signs of apoptosis; strong cell cycle arrest accompanied by moderate apoptosis induction; massive apoptosis. CONCLUSION: 2-DG appears as an interesting new therapeutic agent against cancer in vitro, and should be tested in in vivo studies.


Subject(s)
Antimetabolites/pharmacology , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Proliferation/drug effects , Deoxyglucose/pharmacology , Neoplasms/pathology , Blotting, Western , Caspase 3/metabolism , Enzyme Activation/drug effects , Flow Cytometry , Humans , Neoplasms/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...